Vaxart Inc (NAS:VXRT)
$ 0.7303 0.0538 (7.95%) Market Cap: 129.57 Mil Enterprise Value: 102.71 Mil PE Ratio: 0 PB Ratio: 2.28 GF Score: 51/100

Vaxart Inc to Host Investor Q&A Webcast Transcript

Jun 22, 2022 / 05:00PM GMT
Release Date Price: $3.43 (+3.00%)
Operator

Greetings, and welcome to the Vaxart investor Q&A webcast. (Operator Instructions). A question-and-answer session will follow management's opening remarks. As a reminder, this conference is being recorded.

I will now like to turn the conference over to your host, Brant Biehn, Senior Vice President, Business Operations.

Brant Biehn
Vaxart, Inc. - SVP of Business Operations

Good day, everyone, and welcome to today's call. Joining us from Vaxart are Andrei Floroiu, the Chief Executive Officer; Dr. Sean Tucker, our Founder and Senior Vice President and Chief Scientific Officer; and Dr. James Cummings, our Chief Medical Officer.

But before we get started, I'd like to remind everyone during this conference call that Vaxart may make forward-looking statements, including statements about the company's financial results, financial guidance, its future business strategies and operations and its product development and regulatory progress, including statements about its ongoing or planned clinical trials.

Actual results could differ

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot